EPISODE · Mar 25, 2022 · 22 MIN
H3K27M cell-free tumor DNA tracking in response to ONC201 treatment for diffuse midline glioma
from Neuro-Oncology: The Podcast · host Dr. Iyad Alnahhas, Dr. Carl Koschmann
Dr. Iyad Alnahhas interviews Dr. Carl Koschmann about his and his team's recent manuscript entitled: "Serial H3K27M cell-free tumor DNA (cf-tDNA) tracking predicts ONC201 treatment response and progression in diffuse midline glioma" published online in Neuro-Oncology in February 2022. Read the Study
NOW PLAYING
H3K27M cell-free tumor DNA tracking in response to ONC201 treatment for diffuse midline glioma
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m